to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.
Contact:
Tiffany Hamilton
Head of Communications
Tiffany.Hamilton@ocugen.com
(Tables to follow)
OCUGEN, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)
(Unaudited)
September 30, 2024 December 31, 2023
-------------------- -------------------
Assets
Current assets
Cash $ 38,696 $ 39,462
Prepaid expenses and other
current assets 1,977 3,509
--- --------------- --- --------------
Total current assets 40,673 42,971
Property and equipment, net 17,130 17,290
Restricted cash 305 --
Other assets 3,828 4,286
--- --------------- --- --------------
Total assets $ 61,936 $ 64,547
=== =============== === ==============
Liabilities and stockholders'
equity
Current liabilities
Accounts payable $ 1,494 $ 3,172
Accrued expenses and other
current liabilities 12,475 13,343
Operating lease obligations 477 574
Current portion of long term
debt 1,316 --
--- --------------- --- --------------
Total current liabilities 15,762 17,089
Non-current liabilities
Operating lease obligations,
less current portion 3,419 3,567
Long term debt, net 1,571 2,800
Other non-current liabilities 554 527
--- --------------- --- --------------
Total non-current liabilities 5,544 6,894
--- --------------- --- --------------
Total liabilities 21,306 23,983
--- --------------- --- --------------
Total stockholders' equity 40,630 40,564
--- --------------- --- --------------
Total liabilities and
stockholders' equity $ 61,936 $ 64,547
=== =============== === ==============
OCUGEN, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(Unaudited)
Three months ended Nine months ended
September 30, September 30,
-----------------------
2024 2023 2024 2023
Collaborative
arrangement
revenue $ 1,136 $ 3,699 $ 3,291 $ 4,627
Total revenue 1,136 3,699 3,291 4,627
Operating
expenses
Research and
development 8,108 7,048 23,836 31,794
General and
administrative 6,280 9,082 20,372 26,839
------- ------- ------- -------
Total operating
expenses 14,388 16,130 44,208 58,633
------- ------- ------- -------
Loss from
operations (13,252) (12,431) (40,917) (54,006)
Other income
(expense), net 282 714 743 1,898
======= ======= ======= =======
Net loss $(12,970) $(11,717) $(40,174) $(52,108)
======= ======= ======= =======
(END) Dow Jones Newswires
November 08, 2024 06:45 ET (11:45 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.